HK1108027A1 - Suspension medium for red blood cells - Google Patents
Suspension medium for red blood cellsInfo
- Publication number
- HK1108027A1 HK1108027A1 HK08101850.9A HK08101850A HK1108027A1 HK 1108027 A1 HK1108027 A1 HK 1108027A1 HK 08101850 A HK08101850 A HK 08101850A HK 1108027 A1 HK1108027 A1 HK 1108027A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- blood cells
- red blood
- suspension medium
- amino acids
- inosine
- Prior art date
Links
- 210000003743 erythrocyte Anatomy 0.000 title abstract 2
- 239000000725 suspension Substances 0.000 title abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 abstract 1
- 229930024421 Adenine Natural products 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 abstract 1
- 229930010555 Inosine Natural products 0.000 abstract 1
- 229960000643 adenine Drugs 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 229960003786 inosine Drugs 0.000 abstract 1
- 239000008363 phosphate buffer Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0641—Erythrocytes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- General Engineering & Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200601682A ES2264403B1 (es) | 2006-06-22 | 2006-06-22 | Medio de suspension de hematies. |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1108027A1 true HK1108027A1 (en) | 2008-04-25 |
Family
ID=37813916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08101850.9A HK1108027A1 (en) | 2006-06-22 | 2008-02-20 | Suspension medium for red blood cells |
Country Status (7)
Country | Link |
---|---|
US (2) | US8802385B2 (ja) |
EP (1) | EP1869977B1 (ja) |
JP (1) | JP4673871B2 (ja) |
CN (1) | CN101101293B (ja) |
ES (2) | ES2264403B1 (ja) |
HK (1) | HK1108027A1 (ja) |
MX (1) | MX2007007326A (ja) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003254755B2 (en) | 2002-10-16 | 2007-12-20 | Streck, Inc. | Method and device for collecting and preserving cells for analysis |
US8871434B2 (en) * | 2008-03-21 | 2014-10-28 | Fenwal, Inc. | Red blood cell storage medium for extended storage |
US8968992B2 (en) * | 2008-03-21 | 2015-03-03 | Fenwal, Inc. | Red blood cell storage medium for extended storage |
US11634747B2 (en) | 2009-01-21 | 2023-04-25 | Streck Llc | Preservation of fetal nucleic acids in maternal plasma |
DK2398912T3 (en) | 2009-02-18 | 2017-10-30 | Streck Inc | Conservation of cell-free nucleic acids |
EP2490751B1 (en) | 2009-10-23 | 2016-11-09 | Fenwal, Inc. | Methods and systems for providing red blood cell products with reduced plasma |
CN101718783B (zh) * | 2009-11-25 | 2012-11-14 | 江阴力博医药生物技术有限公司 | 广谱抗人球蛋白卡的制备方法 |
CN101718794B (zh) * | 2009-11-25 | 2013-06-05 | 江阴力博医药生物技术有限公司 | ABO/RhD血型定型检测试剂卡的制备方法 |
CN101701961B (zh) * | 2009-11-25 | 2013-03-06 | 江阴力博医药生物技术有限公司 | Abo血型定型检测试剂卡的制备方法 |
CN101718786B (zh) * | 2009-11-25 | 2012-10-03 | 江阴力博医药生物技术有限公司 | 抗人球蛋白交叉配血卡的制备方法 |
CN101718784B (zh) * | 2009-11-25 | 2013-01-09 | 江阴力博医药生物技术有限公司 | 新生儿溶血病检测试剂盒的制备方法 |
CN101718785B (zh) * | 2009-11-25 | 2012-12-12 | 江阴力博医药生物技术有限公司 | 直接抗人球蛋白试剂卡的制备方法 |
CN101718793B (zh) * | 2009-11-25 | 2013-03-20 | 江阴力博医药生物技术有限公司 | Rh血型分型卡的制备方法 |
EP2536416B1 (en) * | 2010-02-16 | 2018-06-13 | Viacell, LLC | Arginine-containing storage and/or rejuvenating compositions and methods for storing or rejuvenating red blood cells |
US20110229871A1 (en) * | 2010-02-16 | 2011-09-22 | Ericson Daniel G | Nucleoside-containing compositions and methods for treating red blood cells |
DK3225699T3 (da) * | 2012-02-13 | 2020-12-21 | Streck Inc | Blodopsamlingsanordning til forbedret nukleinsyreregulering |
CN103141472B (zh) * | 2013-03-19 | 2014-11-26 | 广西壮族自治区水产研究所 | 香港牡蛎精子超低温冷冻保存以及激活方法 |
EP3024323B1 (en) | 2013-07-24 | 2022-10-19 | Streck, Inc. | Compositions and methods for stabilizing circulating tumor cells |
US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
US11506655B2 (en) | 2016-07-29 | 2022-11-22 | Streck, Inc. | Suspension composition for hematology analysis control |
CN106940377B (zh) * | 2017-03-14 | 2018-09-21 | 北京乐普医疗科技有限责任公司 | 一种凝胶悬浮缓冲液、由其处理得到的凝胶、检测卡及其应用 |
CA3117893A1 (en) * | 2018-11-19 | 2020-05-28 | Hemanext Inc. | Methods for the preservation of reagent red blood cells using carbon monoxide |
BR112022004073A2 (pt) * | 2019-09-05 | 2022-05-31 | Hemanext Inc | Métodos para a preservação de glóbulos vermelhos reagentes usando monóxido de carbono |
CN112684192A (zh) * | 2020-12-25 | 2021-04-20 | 天津市宝坻区人民医院 | 缓血酸铵在abo血型反定型试剂盒中新用途 |
CN113812395A (zh) * | 2021-09-24 | 2021-12-21 | 合肥天一生物技术研究所有限责任公司 | 一种红细胞保存液 |
CN115590014A (zh) * | 2022-09-23 | 2023-01-13 | 无锡托马自然生物技术有限公司(Cn) | 一种红细胞保存液及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4259207A (en) * | 1979-09-19 | 1981-03-31 | American Hospital Supply Corporation | Suspending medium for immunologic reactions |
JPS6112626A (ja) * | 1984-06-28 | 1986-01-21 | Ajinomoto Co Inc | 血液保存剤 |
JPS6115838A (ja) * | 1984-06-29 | 1986-01-23 | Ajinomoto Co Inc | 血液保存剤 |
FR2577321B1 (fr) | 1985-02-08 | 1989-04-28 | Lapierre Yves | Dispositif et procede de mise en evidence d'agglutinats erythrocytaires |
US4774088A (en) * | 1986-01-08 | 1988-09-27 | The United States Of America As Represented By The Deptment Of Health And Human Services | Method and additives for improving the quality and shelf life of stored blood |
US4783401A (en) * | 1986-10-31 | 1988-11-08 | Smithkline Beckman Corporation | Viable cell labelling |
JPH087215B2 (ja) * | 1987-08-24 | 1996-01-29 | シュティフツング・フュア・ディアグノスティッシュ・フォルシュンク | 抗原および/又は抗体の検出方法および検出用の試験キット |
CA2055095C (en) | 1990-11-09 | 2003-05-13 | Johnna B. Hawk | Column agglutination assay and device |
FR2687317B1 (fr) * | 1992-02-13 | 1995-06-23 | Aetsrn | Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique. |
ES2126521B1 (es) * | 1997-06-05 | 1999-11-16 | Transfusion De La Comunidad Va | Metodo para la deteccion de antigenos presentes en la membrana de hematies, propios o acoplados y de anticuerpos irregulares en muestras de suero. |
AU2002213197A1 (en) * | 2000-10-12 | 2002-04-22 | Massachusetts General Hospital | Plasma supplement and use in liver assist systems |
JP2004170127A (ja) * | 2002-11-18 | 2004-06-17 | Olympus Corp | 抗体試験のための血球試薬 |
CA2516123A1 (en) * | 2003-02-17 | 2004-08-26 | Kiwi Ingenuity Limited | Preparation of red blood cells with a modified level of blood group antigen expression and their use in the quality control of blood typing reagents |
FR2857267B1 (fr) * | 2003-07-09 | 2006-03-10 | Lab Francais Du Fractionnement | Formulation stabilisante et solubilisante pour les proteines cryoprecipitables. |
CN101120249A (zh) * | 2004-11-15 | 2008-02-06 | 因韦尔尼斯医药瑞士股份有限公司 | 血型方法系统以及装置 |
US9078428B2 (en) * | 2005-06-28 | 2015-07-14 | Transmedics, Inc. | Systems, methods, compositions and solutions for perfusing an organ |
-
2006
- 2006-06-22 ES ES200601682A patent/ES2264403B1/es active Active
-
2007
- 2007-05-14 EP EP20070380137 patent/EP1869977B1/en active Active
- 2007-05-14 ES ES07380137.5T patent/ES2541135T3/es active Active
- 2007-06-13 CN CN200710111026.3A patent/CN101101293B/zh active Active
- 2007-06-18 MX MX2007007326A patent/MX2007007326A/es active IP Right Grant
- 2007-06-21 JP JP2007163346A patent/JP4673871B2/ja active Active
- 2007-06-22 US US11/766,934 patent/US8802385B2/en active Active
-
2008
- 2008-02-20 HK HK08101850.9A patent/HK1108027A1/xx unknown
-
2010
- 2010-10-29 US US12/915,346 patent/US20110045455A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0702629A (pt) | 2008-02-19 |
CN101101293B (zh) | 2013-03-06 |
ES2264403A1 (es) | 2006-12-16 |
EP1869977A1 (en) | 2007-12-26 |
US20070298406A1 (en) | 2007-12-27 |
US8802385B2 (en) | 2014-08-12 |
EP1869977B1 (en) | 2015-04-29 |
US20110045455A1 (en) | 2011-02-24 |
ES2264403B1 (es) | 2007-11-01 |
JP4673871B2 (ja) | 2011-04-20 |
ES2541135T3 (es) | 2015-07-16 |
JP2008003089A (ja) | 2008-01-10 |
CN101101293A (zh) | 2008-01-09 |
MX2007007326A (es) | 2009-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1108027A1 (en) | Suspension medium for red blood cells | |
WO2006125198A3 (en) | Hemodialysis methods and apparatus | |
WO2003043571A3 (en) | Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation | |
HK1107030A1 (en) | Oligopeptides for reducing elevated blood urea concentration | |
MX2007007881A (es) | Metodo para sintetizar particulas de fosfato de zirconio. | |
WO2006138418A3 (en) | Improvement of cognitive performance with sirtuin activators | |
TW200602065A (en) | Bicarbonate-based peritoneal dialysis solutions | |
WO2007044323A3 (en) | Fusion proteins for blood-brain barrier delivery | |
MY162570A (en) | Buffer system for protein purification | |
HK1088853A1 (en) | Buffered compositions for dialysis | |
EP1733730A3 (en) | Immunemodulating oligosaccharides | |
WO2007109221A3 (en) | Methods for reducing protein aggregation | |
ES2353814T3 (es) | Proteinas n-glicosiladas recombinantes de celulas procariotas. | |
WO2007147001A3 (en) | Lyophilized formulations of anti-egfr antibodies | |
UY29172A1 (es) | Composición de trombina estable | |
TW200700092A (en) | Tigecycline compositions and methods of preparation | |
WO2003072734A3 (en) | Bipolar trans carotenoid salts and their uses | |
WO2007092343A3 (en) | Novel epoprostenol formulation and method of making thereof | |
WO2006041409A8 (en) | Medical solution, method for producing and use thereof | |
TW200733894A (en) | Manufacturing method of ground fish meat product and improving agent for ground fish meat product | |
WO2008039941A3 (en) | Scgb3a2 as a growth factor and anti-apoptotic agent | |
WO2008095093A3 (en) | Method of increasing cellular function and health of glutathione deficient animals | |
DE602006021600D1 (de) | Verfahren zur senkung des blutdrucks | |
EP1552838A4 (en) | RUBROFUSARIN GLYCOSIDE-CONTAINING COMPOSITION | |
MX349837B (es) | Composicion de transglutaminasa seca. |